Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature
- PMID: 16282893
- DOI: 10.1097/01.mph.0000187431.37369.f5
Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature
Abstract
Hepatosplenic gammadelta T-cell lymphoma is an uncommon pediatric disease and is associated with an aggressive and often fatal course. The authors describe the case of an 8-year-old girl who presented with transaminitis and hepatosplenomegaly. Liver biopsy and peripheral blood flow cytometry were diagnostic of hepatosplenic gammadelta T-cell lymphoma. She was treated with multi-agent chemotherapy with cyclophosphamide, vincristine, prednisone, doxorubicin, and high-dose methotrexate but failed to achieve durable remission. She underwent an allogeneic bone marrow transplant from her HLA-identical brother with a preparative regimen including total body irradiation and cyclophosphamide. She is currently alive and has remained in remission for 30 months after transplantation. The authors also review the literature for similar pediatric cases.
Similar articles
-
Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin.Br J Haematol. 2002 Jun;117(4):995-6. doi: 10.1046/j.1365-2141.2002.03537_3.x. Br J Haematol. 2002. PMID: 12060145 No abstract available.
-
Cytotoxic T-lymphocyte differentiation and cytogenetic alterations in gammadelta hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders.Blood. 1997 May 1;89(9):3490-1. Blood. 1997. PMID: 9129060 No abstract available.
-
Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.Int J Clin Exp Pathol. 2009 Oct 15;3(1):110-6. Int J Clin Exp Pathol. 2009. PMID: 19918335 Free PMC article.
-
Hepatosplenic γδ T-cell lymphoma: an overview.Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):360-9. doi: 10.1016/j.clml.2013.03.011. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23876844 Review.
-
Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.Am J Hematol. 2008 Apr;83(4):330-3. doi: 10.1002/ajh.21062. Am J Hematol. 2008. PMID: 17876769 Review.
Cited by
-
Biology and management of rare primary extranodal T-cell lymphomas.Oncology (Williston Park). 2010 Jan;24(1):94-100. Oncology (Williston Park). 2010. PMID: 20187328 Free PMC article. Review.
-
Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.Clin Lymphoma Myeloma Leuk. 2013 Feb;13(1):8-14. doi: 10.1016/j.clml.2012.09.002. Epub 2012 Oct 27. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23107915 Free PMC article.
-
An Unusual Case of Hepatosplenic αβ T-Cell Lymphoma Presenting with Coombs'-Negative Hemolytic Anemia.Clin Med Insights Oncol. 2015 Dec 2;9:123-8. doi: 10.4137/CMO.S35120. eCollection 2015. Clin Med Insights Oncol. 2015. PMID: 26688667 Free PMC article.
-
IL-17 induces radiation resistance of B lymphoma cells by suppressing p53 expression and thereby inhibiting irradiation-triggered apoptosis.Cell Mol Immunol. 2015 May;12(3):366-72. doi: 10.1038/cmi.2014.122. Epub 2014 Dec 29. Cell Mol Immunol. 2015. PMID: 25544504 Free PMC article.
-
Hepatosplenic T-cell lymphoma in children and adolescents.Blood Adv. 2025 Apr 22;9(8):1847-1858. doi: 10.1182/bloodadvances.2025015857. Blood Adv. 2025. PMID: 39874497 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials